DexCom
DXCMHealthcare · Medical Devices · US86.04USD-1.90%
StratDeckDexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally.
Price · Past year
Loading chart…
Checks
- Pass: Price trending up The figures
- Pass: Sales growing faster than its peers The figures
- Pass: More profitable than similar companies The figures
- Pass: Analysts rate it a strong buy The figures
- Fail: Costs more than similar companies The figures
- Pass: Beat profit forecasts The figures
Share
Keep researching
Where next from DXCM
Other stocks you may like
Fundamentals
SEC EDGAR
Yahoo FinanceShowHide
What's happening?
DXCM is lagging Healthcare this month The figures
- 1D
- -1.90%
- 7D
- +2.29%
- 1M
- -1.49%
- 3M
- +12.25%
- 6M
- +34.48%
- YTD
- +29.64%
What is the market expecting?
StratDeckCosts more than similar companies, and analysts expect the price to rise The figures
Value score vs Healthcare peers
14- Fwd P/E27.510
- P/B12.49
- P/E34.130
- Rev growth+13.1%85
Not scored on Yield. The rest were reweighted to make up the difference.
Is the business delivering?
Sales are growing faster than at similar companies, and profit per share is up The figures
Earnings by quarter
Latest quarter 249M · +49.6M on the quarter before · +69.3M on a year earlier
- 135MOct24-8.90M
- 152MFeb25+17.1M
- 105MMay25-46.3M
- 180MJul25+74.4M
- 284MOct25+104M
- 267MFeb26-16.5M
- 200MApr26-67.8M
- 249MJul26+49.6M
How does it compare?
Nearest in Healthcare on valueStratDeckDXCM is worse value than most Healthcare stocks The figures
What happens next?
Reports next on 29 Oct, in 12 days
Daily market updates
Get the brief
Get an interesting stock pick, updates on the AI sector, information on the biggest movers of the day, and more, in the Monday, Wednesday and Friday email.